Clinic
Pediatrics Kid-Med, LLC
Pediatrics Kid-Med, LLC was paid $8.86M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoPEDIATRICS KID-MED, LLC
GRETNA, LA 70056
GRETNA, LA 70056
33aNPI1386626356assigned 11/16/2005
33bProvider typeClinic/Center
28Total paid$8.86M
24GClaims264,033
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Louisiana
Rank by total paid#1 of 112
Median peer was paid$138K
This provider vs. median64×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,447 | $1.39M | |
| 2019 | 42,437 | $1.54M | |
| 2020 | 33,828 | $1.18M | |
| 2021 | 34,339 | $1.10M | |
| 2022 | 35,549 | $1.36M | |
| 2023 | 41,413 | $1.19M | |
| 2024incomplete | 35,020 | $1.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 40,106 | 37,052 | $1.86M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 21,521 | 19,819 | $1.47M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.1% | 12,246 | 11,315 | $720K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8.0% | 25,481 | 23,681 | $708K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.7% | 10,090 | 9,723 | $678K |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | 7.2% | 3,215 | 283 | $637K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.0% | 6,704 | 6,473 | $444K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4.1% | 27,522 | 25,504 | $365K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.4% | 4,205 | 3,999 | $299K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.1% | 18,057 | 17,152 | $271K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.9% | 837 | 658 | $260K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.9% | 3,225 | 3,069 | $258K |
57 more codes
| 99468 | 1.4% | 235 | $124K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 1.4% | 2,532 | $122K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 3,659 | $119K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,048 | $89K |
| 87634 | <1% | 1,131 | $64K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 940 | $37K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 6,049 | $36K |
| 99460 | <1% | 822 | $33K | |
| 90474 | <1% | 3,887 | $32K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 330 | $28K |
| 87486 | <1% | 916 | $25K | |
| 87581 | <1% | 909 | $25K | |
| 92551 | <1% | 2,987 | $23K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 291 | $19K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 45 | $17K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,492 | $13K |
| 94664 | <1% | 1,545 | $13K | |
| 69210 | <1% | 532 | $13K | |
| 99173 | <1% | 5,427 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 698 | $8K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 97 | $6K |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 77 | $5K |
| 99462 | <1% | 221 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 393 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 30 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 112 | $3K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 40 | $3K |
| 86769 | <1% | 110 | $2K | |
| 0072A | <1% | 64 | $2K | |
| 0071A | <1% | 43 | $2K | |
| 99188 | <1% | 93 | $1K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 16 | $1K |
| 94760 | <1% | 2,086 | $1K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 16 | $974.46 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 402 | $459.54 |
| 87807 | <1% | 33 | $411.06 | |
| 36416 | <1% | 64 | $40.48 | |
| 90633 | <1% | 4,668 | $8.34 | |
| 90651 | <1% | 2,608 | $3.22 | |
| 90677 | <1% | 1,046 | $1.96 | |
| 90647 | <1% | 802 | $0.89 | |
| 90686 | <1% | 4,464 | $0.02 | |
| 90716 | <1% | 1,023 | $0.01 | |
| 90707 | <1% | 1,019 | $0.01 | |
| 90723 | 0% | 7,147 | $0.00 | |
| 90696 | 0% | 889 | $0.00 | |
| 91307 | 0% | 194 | $0.00 | |
| 90620 | 0% | 826 | $0.00 | |
| 90734 | 0% | 2,424 | $0.00 | |
| 90710 | 0% | 941 | $0.00 | |
| 90685 | 0% | 1,772 | $0.00 | |
| 90681 | 0% | 3,889 | $0.00 | |
| 90670 | 0% | 8,281 | $0.00 | |
| 90648 | 0% | 6,470 | $0.00 | |
| 90700 | 0% | 1,400 | $0.00 | |
| 90715 | 0% | 573 | $0.00 | |
| 91300 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANAND, HARISH (OWNER)